Financial benefit of combining two expensive drugs for CLL
Venetoclax and ibrutinib are two relatively new drugs being used for the treatment of chronic lymphocytic leukemia (CLL), and although studies are suggesting them to be more effective than conventiona... Author: VJHemOnc Added: 12/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 15, 2017 Category: Cancer & Oncology Source Type: podcasts

Primary analysis of MURANO study data for R/R CLL
Updates from the highly anticipated Phase III MURANO study (NCT02005471) in relapsed/refractory chronic lymphocytic leukemia (CLL) were presented at the American Society of Hematology (ASH) 2017 Annua... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Exciting novel AML treatment: venetoclax plus cobimetinib or idasanutlin in elderly patients
Venetoclax combinations have shown excellent results in chronic lymphocytic leukemia (CLL), but are now, excitingly, displaying fantastic preliminary outcomes in acute lymphocytic leukemia (ALL). In t... Author: VJHemOnc Added: 12/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 13, 2017 Category: Cancer & Oncology Source Type: podcasts

Can CLL Treatment Start Earlier?
For some chronic lymphocytic leukemia (CLL) patients, the watch-and-wait period can be unsettling, leaving them wondering why a life-threatening condition hasnt received treatment yet. Why doesnt tr... Author: patientpower Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts

What Are the Common Symptoms of CLL?
While some chronic lymphocytic leukemia (CLL) patients are asymptomatic, the disease can cause a wide range of symptomsand indicate disease progression. Dr. Stephen Spurgeon, from the OHSU Knight Can... Author: patientpower Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Understanding the Basics of CLL
What is exactly going on in the body of a person with chronic lymphocytic leukemia (CLL)? Watch this video to increase your understanding of the condition as CLL experts Dr. Michael Keating and Dr. Ka... Author: patientpower Added: 11/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2017 Category: Cancer & Oncology Source Type: podcasts

Andrew Schorr: How I Am Preparing for CLL Retreatment
Andrew Schorr, Patient Power Founder and frequent host, is used to interviewing patients, physicians and care partners. As Andrew prepares to begin retreatment for his chronic lymphocytic leukemia (CL... Author: patientpower Added: 07/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2017 Category: Cancer & Oncology Source Type: podcasts

What Should Patients Know About the 2017 iwCLL Conference?
What CLL research did experts discuss at the recent 2017 International Workshop on Chronic Lymphocytic Leukemia (iwCLL)? In attendance at the conference was Dr. Nicole Lamanna, from Columbia Universit... Author: patientpower Added: 07/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of GENUINE study for CLL
Jeff Sharman, MD of Willamette Valley Cancer Center gives an overview of his presentation, which focused on the GENUINE trial for patients with chronic lymphocytic leukemia. This was recorded at the 2... Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

What are the emerging trends in CLL management?
Jeff Sharman, MD of Willamette Valley Cancer Center discusses the emerging trends for management of chronic lymphocytic leukemia at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

The 2017 IwCLL Meeting: Expert Highlights
Leading CLL specialists recently gathered to discuss developing research at the 2017 International Workshop on Chronic Lymphocytic Leukemia meeting, also known as iwCLL. Expert Dr. William Wierda atte... Author: patientpower Added: 06/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 8, 2017 Category: Cancer & Oncology Source Type: podcasts

CLL and SLL: Whats the Difference?
How are small lymphocytic leukemia (SLL) and chronic lymphocytic leukemia (CLL) different? Leading experts Dr. Michael Keating and Dr. Nicole Lamanna explain the similarities and differences between S... Author: patientpower Added: 03/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Novel agents in the pipeline for CLL & lymphoma
In this presentation from Lymphoma & Myeloma 2016, Dr. Swaminathan P. Iyer discusses novel agents in the pipleine for the treatment of chronic lymphocytic leukemia (CLL) and lymphoma.<br /><br />Click to Earn... Author: imedex Added: 03/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 8, 2017 Category: Cancer & Oncology Source Type: podcasts

Optimal approaches for the management of patients with deletion 17p
In this presentation from Lymphoma & Myeloma 2016, Dr. Neil E. Kay discusses optimal approaches for the management of chronic lymphocytic leukemia (CLL) patients with deletion 17p.<br /><br />Click to Earn CM... Author: imedex Added: 03/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 8, 2017 Category: Cancer & Oncology Source Type: podcasts

Highlight of FDA approvals 2016: Venetoclax
In this presentation from Lymphoma &amp; Myeloma 2016, Dr. Richard R. Furman discusses the recent FDA approval of venetoclax for the treatment of chronic lymphocytic leukemia (CLL).<br /><br />Earn CME credit... Author: imedex Added: 02/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2017 Category: Cancer & Oncology Source Type: podcasts